CN104069323A

CN104069323A - Traditional Chinese medicine for external application for treating bronchial asthma

Info

Publication number: CN104069323A
Application number: CN201410286995.2A
Authority: CN
Inventors: 马绍美
Original assignee: Individual
Current assignee: Individual
Priority date: 2014-06-16
Filing date: 2014-06-16
Publication date: 2014-10-01

Abstract

The invention discloses a traditional Chinese medicine for external application for treating bronchial asthma. According to traditional Chinese medical science, phlegm stagnation in the lung is the root of bronchial asthma, and the root cause of the bronchial asthma is qi deficiency of the lung and the kidney. The traditional Chinese medicine for external application is prepared from mountain sandalwood, medicago falcate, amaranthus caudatus root, rhizome of longspurred fairybells, acanthus ilicifolius, mountain crab, phellodendron amurense, Chinese anaphalis, platycarya strobilacea fruit, and delphinium ajacis. The traditional Chinese medicine for external application for treating bronchial asthma is prepared by a manufacturing laboratory of the institute, and clinical tests prove that the total effective rate is 94.2%, which is better than that of the control group obviously, and the curative effect is remarkable.

Description

A kind of external application of Chinese medicine agent for the treatment of bronchial asthma

Technical field

The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of external application of Chinese medicine agent for the treatment of bronchial asthma.

Background technology

Bronchial asthma is a kind of with the various kinds of cell chronic airway inflammation that particularly inflammatory cell such as mastocyte, eosinophilic granulocyte and T lymphocyte participates in and the disease taking airway hyperreactivity as feature, western medical treatment generally adopts glucocorticoid to treat, this medical instrument has the antianaphylactic powerful effect of drug resistance, but life-time service side effect is obvious.I am in clinical position for many years, adopt treatment by Chinese herbs, not only good effect, and side effect is little, particularly adopts the outer coating method treatment of the traditional Chinese medical science, pass through Drug Percutaneous Absorption, directly act on affected part, promote inflammatory resolution, the symptoms such as alleviation is panted, tachypnea, improve resistance, to reach the object of accelerating treatment bronchial asthma.

Summary of the invention

The object of this invention is to provide a kind of external application of Chinese medicine agent for the treatment of bronchial asthma.Long-standing of Bronchial Asthma is expectorant stasis of blood volt lung, and disease is originally insufficiency of QI of the lung and kidney.Bronchial asthma belongs to Chinese medicine " asthma " category.Chinese traditional treatment principle is kidney and spleen invigorating, depressed liver-energy dispersing and QI regulating, removing heat from the lung and dissipating phlegm.

The object of the invention is to be achieved through the following technical solutions, the external application of Chinese medicine agent of this treatment bronchial asthma is made up of the Chinese medicine of following weight portion: Radix Vaccinii Delavayi 3-9 part, Herba medicaginis falcatae 9-13 part, Radix Amaranthi Caudati 6-10 part, Rhizoma Dispori Calcarati 9-15 part, Radix seu Caulis Acanthi Ilicifolii 10-20 part, Geastrum hygrometricum Pers. 1-3 part, Fructus phellodendri amurensis 3-6 part, Herba Anaphalidis 6-10 part, Fructus Platycaryae strobilaceac 9-15 part, Radix Consolidae 2-5 part.

Preferably, 6 parts of Radix Vaccinii Delavayi, 11 parts of Herba medicaginis falcatae, 8 parts of Radix Amaranthi Caudatis, 12 parts of Rhizoma Dispori Calcaratis, 15 parts of Radix seu Caulis Acanthi Ilicifoliis, 2 parts of Geastrum hygrometricum Pers., 4 parts of Fructus phellodendri amurensiss, 8 parts of Herba Anaphalidiss, 12 parts of Fructus Platycaryae strobilaceacs, 3.5 parts of Radix Consolidaes.

The above-mentioned Chinese medicine pulverization of preparation method, utilizes Mel, Sucus Zingberis furnishing pasty state (ratio of Mel and Sucus Zingberis is 1: 2).

Fang Zhong: the pleasant removing food stagnancy of Radix Vaccinii Delavayi; Herba medicaginis falcatae alleviating distention in middle-JIAO, the therapeutic method to keep the adverse QI flowing downwards, spleen invigorating tonify deficiency; Radix Amaranthi Caudati strengthening by means of tonics; Rhizoma Dispori Calcarati promoting the production of body fluid and benefiting QI, nourishing YIN and moistening the lung; Radix seu Caulis Acanthi Ilicifolii expectorant detumescence, eliminating stasis to stop pain; Geastrum hygrometricum Pers. lung heat clearing, antiinflammatory, detoxify, invigorate blood circulation; Fructus phellodendri amurensis eliminating phlegm and stopping cough; Herba Anaphalidis relieving cough and expelling phlegm, the antiinflammatory of relievining asthma; The pleasant pain relieving of Fructus Platycaryae strobilaceac, reduce phlegm, parasite killing, dispel the wind, subside a swelling; Stomachache is relievingd asthma, controlled to Radix Consolidae.

Clinical data

1, the routine patient of physical data 103 all meets bronchial asthma diagnostic criteria, is divided at random treatment group 52 and matched group 51 examples.Treatment group: male 27 examples, female's 25 examples, 20～52 years old age, average 43.1 years old, the course of disease 1 year～26 years.Matched group man 26 examples, female's 25 examples, the age is 19～53 years old, average 42.9 years old, the course of disease 1.5 years～27 years.Two groups at aspects such as sex, age, the course of disease, the state of an illness without significant difference (P > 0.05), there is comparability.

2, diagnostic criteria (1) repeatedly shows effect and pants, out of breath, uncomfortable in chest or cough, how relevant with contact allergen, cold air, physics, chemical irritation and viral upper respiratory tract infection, motion etc.(2) taking expiratory phase as main wheezing sound, expiratory phase extends at two lung audibles and be dispersed in or diffusivity when outbreak.(3) above-mentioned symptom and sign can be alleviated or spontaneous remission through treatment.(4) except other diseases causedly pant, out of breath, uncomfortable in chest and cough.

3, Therapeutic Method treatment group is used external application of Chinese medicine agent of the present invention, takes Radix Vaccinii Delavayi 6g, Herba medicaginis falcatae 11g, Radix Amaranthi Caudati 8g, Rhizoma Dispori Calcarati 12g, Radix seu Caulis Acanthi Ilicifolii 15g, Geastrum hygrometricum Pers. 2g, Fructus phellodendri amurensis 4g, Herba Anaphalidis 8g, Fructus Platycaryae strobilaceac 12g, Radix Consolidae 3.5g.Pulverization, utilizes Mel, Sucus Zingberis furnishing pasty state (ratio of Mel and Sucus Zingberis is 1: 2).Usage: take this external application of Chinese medicine agent 50g, be divided into 6 equal portions, pinch into ball, stick respectively in bilateral pulmonary, the heart, ke shu, and with immobilization with adhesive tape, paste 8h at every turn, 5 days 1 time was for 3 times 1 course for the treatment of.As paste rear part have send out overworked, heating and comfort person can paste a few hours, take off again after to be dried, 10 days, interval between two courses for the treatment of, paste 1 3～74 days dog days.Matched group gives oral prednisone, and a 5mg 2 times on the one, 15 days each courses for the treatment of, all treats for two groups and adds up curative effect four courses for the treatment of.

4, criterion of therapeutical effect is cured: cough, cough up phlegm, asthma, uncomfortable in chest, pulmonary rale all disappears, pulmonary function, eosinophilic granulocyte, IgG, 1gE are all normal, in two years without recurring; Effective: clinical symptoms, sign disappear substantially.Lab testing substantially reaches or approaches normal; Effective: clinical symptoms is improved, and lab testing takes a turn for the better to some extent, and recurrent number is than former minimizing; Invalid: symptom and sign is without improvement, and lab testing is without changing or increasing the weight of.

5, curative effect comparison after four courses for the treatment of of two groups of therapeutic outcomes treatment, treatment group 52 examples, wherein cure 20 examples (38.4%), effective 16 examples (30.8%), effective 13 examples (25%), invalid 3 examples (5.8%), total effective rate 94.2%; Matched group 51 examples, wherein cure 8 examples (15.7%), effective 12 examples (23.5%), effective 15 examples (29.4%), invalid 16 examples (31.4%), total effective rate 68.6%.Two groups of comparisons, treatment group cure rate, total effective rate are obviously better than matched group, have comparability (P < 0.05).

Detailed description of the invention

Embodiment mono-: take Radix Vaccinii Delavayi 6g, Herba medicaginis falcatae 11g, Radix Amaranthi Caudati 8g, Rhizoma Dispori Calcarati 12g, Radix seu Caulis Acanthi Ilicifolii 15g, Geastrum hygrometricum Pers. 2g, Fructus phellodendri amurensis 4g, Herba Anaphalidis 8g, Fructus Platycaryae strobilaceac 12g, Radix Consolidae 3.5g, pulverization, utilizes Mel, Sucus Zingberis furnishing pasty state (ratio of Mel and Sucus Zingberis is 1: 2).

Embodiment bis-: take 9 parts of Radix Vaccinii Delavayi, 9 parts of Herba medicaginis falcatae, 10 parts of Radix Amaranthi Caudatis, 9 parts of Rhizoma Dispori Calcaratis, 20 parts of Radix seu Caulis Acanthi Ilicifoliis, 1 part of Geastrum hygrometricum Pers., 6 parts of Fructus phellodendri amurensiss, 6 parts of Herba Anaphalidiss, 15 parts of Fructus Platycaryae strobilaceacs, 5 parts of Radix Consolidaes, pulverization, utilizes Mel, Sucus Zingberis furnishing pasty state (ratio of Mel and Sucus Zingberis is 1: 2).

Embodiment tri-: take 3 parts of Radix Vaccinii Delavayi, 13 parts of Herba medicaginis falcatae, 6 parts of Radix Amaranthi Caudatis, 15 parts of Rhizoma Dispori Calcaratis, 10 parts of Radix seu Caulis Acanthi Ilicifoliis, 3 parts of Geastrum hygrometricum Pers., 3 parts of Fructus phellodendri amurensiss, 10 parts of Herba Anaphalidiss, 9 parts of Fructus Platycaryae strobilaceacs, 2 parts of Radix Consolidaes, pulverization, utilizes Mel, Sucus Zingberis furnishing pasty state (ratio of Mel and Sucus Zingberis is 1: 2).

Claims

1. treat an external application of Chinese medicine agent for bronchial asthma, it is characterized in that this external application of Chinese medicine agent is made up of the Chinese medicine of following weight portion: Radix Vaccinii Delavayi 3-9 part, Herba medicaginis falcatae 9-13 part, Radix Amaranthi Caudati 6-10 part, Rhizoma Dispori Calcarati 9-15 part, Radix seu Caulis Acanthi Ilicifolii 10-20 part, Geastrum hygrometricum Pers. 1-3 part, Fructus phellodendri amurensis 3-6 part, Herba Anaphalidis 6-10 part, Fructus Platycaryae strobilaceac 9-15 part, Radix Consolidae 2-5 part.

2. a kind of external application of Chinese medicine agent for the treatment of bronchial asthma according to claim 1, is characterized in that this Chinese medicine preparation is made up of the Chinese medicine of following weight portion: 6 parts of Radix Vaccinii Delavayi, 11 parts of Herba medicaginis falcatae, 8 parts of Radix Amaranthi Caudatis, 12 parts of Rhizoma Dispori Calcaratis, 15 parts of Radix seu Caulis Acanthi Ilicifoliis, 2 parts of Geastrum hygrometricum Pers., 4 parts of Fructus phellodendri amurensiss, 8 parts of Herba Anaphalidiss, 12 parts of Fructus Platycaryae strobilaceacs, 3.5 parts of Radix Consolidaes.